Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Pneumococcal diseases such as otitis media, pneumonia, and meningitis are invariably preceded by nasopharyngeal colonization, and herd immunity against pneumococcal disease requires protection against colonization. An early study in mice demonstrated that mucosal immunization with cholera toxin B subunit as adjuvant could elicit solid mucosal immunity. Recent data from several laboratories provides support for three different mechanisms by which adaptive immunity can provide protection against colonization. (1) IL-17-dependent T cell immunity can recruit PMN to sites of colonization. This IL-17-dependent immunity can be elicited by immunization with antigen plus a mucosal adjuvant, or can be elicited by colonization itself. (2) Immunity against colonization can be mediated by mucosal IgA and at the mucosal surface passive mucosal IgA antibody provides much better protection against carriage than passive IgG antibody. (3) Complement-fixing IgG antibody can protect against colonization and may act by protecting against colonization of bacteria.

Original publication




Conference paper

Publication Date





25 - 27


Animals, Antibodies, Bacterial, Antigens, Bacterial, Bacterial Proteins, Colony Count, Microbial, Humans, Immunity, Mucosal, Pneumococcal Infections, Respiratory Mucosa, Respiratory Tract Infections, Streptococcus pneumoniae